139 related articles for article (PubMed ID: 20354788)
1. Access to children's medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007.
Ragupathy R; Tordoff J; Norris P; Reith D
Pharm World Sci; 2010 Jun; 32(3):386-93. PubMed ID: 20354788
[TBL] [Abstract][Full Text] [Related]
2. A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand.
Ragupathy R; Aaltonen K; Tordoff J; Norris P; Reith D
Pharmacoeconomics; 2012 Nov; 30(11):1051-65. PubMed ID: 22963187
[TBL] [Abstract][Full Text] [Related]
3. Trends in accessibility to medicines for children in New Zealand: 1998-2002.
Chui J; Tordoff J; Kennedy J; Reith D
Br J Clin Pharmacol; 2004 Mar; 57(3):322-7. PubMed ID: 14998428
[TBL] [Abstract][Full Text] [Related]
4. Changes in availability of paediatric medicines in Australia between 1998 and 2002.
Chui J; Tordoff J; Reith D
Br J Clin Pharmacol; 2005 Jun; 59(6):736-42. PubMed ID: 15948941
[TBL] [Abstract][Full Text] [Related]
5. Effect of the pediatric exclusivity provision on children's access to medicines.
Grieve J; Tordoff J; Reith D; Norris P
Br J Clin Pharmacol; 2005 Jun; 59(6):730-5. PubMed ID: 15948940
[TBL] [Abstract][Full Text] [Related]
6. Access to prescribing information for paediatric medicines in the USA: post-modernization.
Young L; Lawes F; Tordoff J; Norris P; Reith D
Br J Clin Pharmacol; 2009 Mar; 67(3):341-6. PubMed ID: 19220278
[TBL] [Abstract][Full Text] [Related]
7. Widening consumer access to medicines through switching medicines to non-prescription: a six country comparison.
Gauld NJ; Kelly FS; Kurosawa N; Bryant LJ; Emmerton LM; Buetow SA
PLoS One; 2014; 9(9):e107726. PubMed ID: 25251434
[TBL] [Abstract][Full Text] [Related]
8. Importation of prescription medicines into New Zealand: a snapshot of intercepted products.
Sheridan J; Kelly F; Oughton J; Al-Jubbawey A; Grey M; Hussein S; Jayetileke E; Mehta M; Nair S
Int J Clin Pharm; 2011 Feb; 33(1):80-7. PubMed ID: 21365399
[TBL] [Abstract][Full Text] [Related]
9. The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand.
Aaltonen K; Ragupathy R; Tordoff J; Reith D; Norris P
Value Health; 2010; 13(1):148-56. PubMed ID: 19744294
[TBL] [Abstract][Full Text] [Related]
10. Access to new medicines in New Zealand compared to Australia.
Wonder M; Milne R
N Z Med J; 2011 Nov; 124(1346):12-28. PubMed ID: 22143849
[TBL] [Abstract][Full Text] [Related]
11. Patient access to medicines in two countries with similar health systems and differing medicines policies: Implications from a comprehensive literature review.
Babar ZU; Gammie T; Seyfoddin A; Hasan SS; Curley LE
Res Social Adm Pharm; 2019 Mar; 15(3):231-243. PubMed ID: 29678413
[TBL] [Abstract][Full Text] [Related]
12. Exploring the implications of a fixed budget for new medicines: a study of reimbursement of new medicines in Australia and New Zealand.
Taylor C; Wonder M
Aust Health Rev; 2015 Sep; 39(4):455-461. PubMed ID: 25751688
[TBL] [Abstract][Full Text] [Related]
13. Establishing a baseline for the monitoring of medicines availability for children in the UK: 1998-2002.
Balakrishnan K; Tordoff J; Norris P; Reith D
Br J Clin Pharmacol; 2007 Jan; 63(1):85-91. PubMed ID: 16869822
[TBL] [Abstract][Full Text] [Related]
14. Pediatric licensing status and the availability of suitable formulations for new medical entities approved in the United States between 1998 and 2002.
Balakrishnan K; Grieve J; Tordoff J; Norris P; Reith D
J Clin Pharmacol; 2006 Sep; 46(9):1038-43. PubMed ID: 16920899
[TBL] [Abstract][Full Text] [Related]
15. Subsidised access to new melanoma drugs: in need of further innovation?
Wonder M; Fisher R
N Z Med J; 2016 Aug; 129(1440):37-54. PubMed ID: 27538038
[TBL] [Abstract][Full Text] [Related]
16. The role of Government policy in supporting nurse-led care in general practice in the United Kingdom, New Zealand and Australia: an adapted realist review.
Hoare KJ; Mills J; Francis K
J Adv Nurs; 2012 May; 68(5):963-80. PubMed ID: 22070658
[TBL] [Abstract][Full Text] [Related]
17. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
18. Health insurance markets and income inequality: findings from an international health policy survey.
Schoen C; Davis K; DesRoches C; Donelan K; Blendon R
Health Policy; 2000 Mar; 51(2):67-85. PubMed ID: 10699676
[TBL] [Abstract][Full Text] [Related]
19. A national analysis of dental waiting lists and point-in-time geographic access to subsidised dental care: can geographic access be improved by offering public dental care through private dental clinics?
Dudko Y; Kruger E; Tennant M
Rural Remote Health; 2017; 17(1):3814. PubMed ID: 28092965
[TBL] [Abstract][Full Text] [Related]
20. Dosing information for paediatric patients: are they really "therapeutic orphans"?
Tan E; Cranswick NE; Rayner CR; Chapman CB
Med J Aust; 2003 Aug; 179(4):195-8. PubMed ID: 12914509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
